{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-044242","form_type":"8-K","ticker":null,"cik":"0001831874","company_name":"Iris Acquisition Corp","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.544441+00:00","generated_at":"2026-06-04T01:56:07.998748+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Iris Acquisition Corp extends business combination deadline with Liminatus Pharma to July 31, 2024","bullets":["Third amendment to business combination agreement pushes outside date from March 9, 2024 to July 31, 2024.","PIPE equity and convertible note subscription agreements also extended to July 31, 2024.","All other terms of the BCA and subscription agreements remain unchanged.","This is the third extension since the original BCA was signed in November 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-044242","json":"https://secwatch.observer/filing/0001104659-24-044242.json","markdown":"https://secwatch.observer/filing/0001104659-24-044242.md","text":"https://secwatch.observer/filing/0001104659-24-044242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/0001104659-24-044242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/tm2411213d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:56:07.998748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f845353d607cb4540551c6398b9be5805762489","claim":"Iris Acquisition Corp amended Third BCA Amendment with Liminatus Pharma, LLC (effective 2024-03-09).","evidence_excerpt":"On March 9, 2024, Iris Acquisition Corp, a Delaware corporation (“we,” “our,” or “Iris”), Iris Parent Holding Corp., a Delaware corporation (“ParentCo”) and Liminatus Pharma, LLC, a Delaware limited liability company (“Liminatus”), entered into a third amendment (the “Third BCA Amendment”) to the Business Combination Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/0001104659-24-044242-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Liminatus Pharma, LLC"},{"label":"Effective","value":"2024-03-09"}],"fact_type":"material_agreement"},{"claim_id":"60c7ca15d845bcde045d3e45941343362b206db3","claim":"Iris Acquisition Corp amended Second Amendment to Convertible Note PIPE with PIPE subscriber (effective 2024-03-09).","evidence_excerpt":"ParentCo, Iris and the PIPE subscriber entered into a second amendment (the “Second Amendment to Convertible Note PIPE”) to the Convertible Note Subscription Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/0001104659-24-044242-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"PIPE subscriber"},{"label":"Effective","value":"2024-03-09"}],"fact_type":"material_agreement"},{"claim_id":"c7e3652a593f481d0893b61f8fef386d096fecc9","claim":"Iris Acquisition Corp amended Second Amendment to Equity PIPE with PIPE subscriber (effective 2024-03-09).","evidence_excerpt":"ParentCo, Iris and the PIPE subscriber entered into a second amendment (the “Second Amendment to Equity PIPE”) to the Equity Subscription Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/0001104659-24-044242-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"PIPE subscriber"},{"label":"Effective","value":"2024-03-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}